Results 351 to 360 of about 5,734,618 (390)

Patient perspectives on adverse event investigations in health care. [PDF]

open access: yesBMC Health Serv Res
Dijkstra-Eijkemans RI   +4 more
europepmc   +1 more source

Endo- and myocarditis as a severe complication of immune-related adverse event treatment: a case report. [PDF]

open access: yesEur Heart J Case Rep
Van den Bosch L   +4 more
europepmc   +1 more source

Hospital COVID-19 Burden and Adverse Event Rates.

open access: yesJAMA Netw Open
Metersky ML   +8 more
europepmc   +1 more source

Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database

Multiple Sclerosis, 2020
Background: Rituximab and ocrelizumab are anti-CD20 monoclonal antibodies that have shown a marked reduction in multiple sclerosis (MS) inflammatory activity. However, their real-world safety profile has not been adequately compared.
Natalia Gonzalez Caldito   +3 more
semanticscholar   +1 more source

Adverse Events and Preventable Adverse Events in Children

Pediatrics, 2005
Context. Patient safety has been recognized as an important problem in health care. However, knowledge about adverse events and preventable adverse events in children is relatively limited. Objective. To describe the incidence and types of adverse events and preventable adverse events in children. Design.
Stuart H. Altman   +4 more
openaire   +3 more sources

Reduction of Adverse Events

Pediatrics In Review, 2020
1. Leslie J. Davis, DO*,† 2. David A. Wathen, DO*,† 1. *Saint Louis University School of Medicine, St Louis, MO 2. †SSM Health Cardinal Glennon Children’s Hospital, St Louis, MO For those who work in health-care, it is not difficult to think of examples from our careers where patient safety has been compromised, whether that be a near-miss ...
Leslie J. Davis   +3 more
openaire   +3 more sources

Adverse events of PARP inhibitors

Česká gynekologie, 2021
An evaluation of the safety of poly-ADP-ribose-polymerase inhibitors (PARPi) in ovarian cancer treatment.An analysis of the studies on PARP inhibitors, a summary of the most common and serious adverse events.According to the studies, the most common adverse events of PARPi include hematotoxicity, nausea and vomiting.
Jaroslav Klát, Martina Romanová
openaire   +3 more sources

Hepatobiliary Adverse Events

2020
Immune checkpoint inhibitors (ICIs) are increasingly used for multiple cancer types. Hepatotoxicity is a reported adverse event of ICI treatment. It can present as asymptomatic elevation of aspartate transaminase and alanine transaminase or symptomatic hepatitis with fever, malaise, and even death in rare cases.
Hamzah Abu-Sbeih, Yinghong Wang
openaire   +3 more sources

Screening for adverse events

Journal of Evaluation in Clinical Practice, 1999
Abstract: Adverse events (AEs) in medical patients are common, costly, and often preventable. Development of quality improvement programs to decrease the number and impact of AEs demands effective methods for screening for AEs on a routine basis.
Andrew S. Karson, David W. Bates
openaire   +3 more sources

Adverse events and adverse outcomes

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 2003
Adverse events and adverse outcomes resulting from medical and surgical care have become frequent topics of discussion in major medical journals, as well as stories in the print and broadcast media. Death and disability from mistakes related to organ transplant surgery, dispensing incorrect medications, and incorrect diagnoses have been subjects of ...
openaire   +3 more sources

Home - About - Disclaimer - Privacy